Pliant Therapeutics
CA - South SFBiotechnology
Focus: Pliant Therapeutics is a mid-cap biotechnology company focused on developing treatments for fibrotic diseases, with a pipeline spanning respiratory, oncology, and cholestatic liver disease indications.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Open Jobs
1-2 this month
Stable — net -2 jobs in 30d
1 added, 3 removed. Backfill posture.
Should You Work at Pliant Therapeutics?
AI assessmentBest for mission-driven scientists seeking fibrosis-focused discovery and early-stage development work at a financially solvent but operationally lean biotech.
Why Work Here
- Clear therapeutic focus on fibrotic diseases with multiple Phase 2 programs in high-unmet-need areas like idiopathic pulmonary fibrosis and primary sclerosing cholangitis
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PLN-101095
Metastatic Solid TumorClinical Trials (1)
NCT06270706A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1Help build intelligence for Pliant Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.